However, considering that pitavastatin treatment moderately enhanced type II IFN-induced IP10 mRNA expression (Appendix Fig. S5), it remains possible that type II IFN-mediated responses are affected by statins in the context of secondary or late-phase of viral infections, where T cells produce type II IFNs. The gene discussed is CXCL10; the disease is viral infectious disease.